Found 33 matching trials
Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)
PHASE2The purpose of the study is to find out the effects and the safety of an in...
Location
H. Lee Moffitt Cancer Center and Research Institute
Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis
PHASE1This study will assess safety as well as establish a Recommended Phase II d...
Location
Novartis Investigative Site
Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
PHASE1The purpose of this study is to determine the safety and clinical efficacy ...
Location
Georgia Regents University
Panobinostat/Velcade in Multiple Myeloma
PHASE1Multiple myeloma (MM) accounts for approximately 1% of all malignancies and...
Location
Myeloma Institute for Research and Therapy University of Arkansas for Medical Sciences
Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
PHASE2The purpose of this study is evaluate the response, safety and tolerability...
Location
Duke University Medical Center
A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer
PHASE1This Phase Ib dose escalation study is designed to characterize the safety,...
Location
Novartis Investigative Site
Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
University of Texas MD Anderson Cancer Center
LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma
PHASE1The purpose of this research study is to determine the amount of LBH589 tha...
Location
Northwestern University
Efficacy and Safety of LBH589B in Adult Patients With Multiple Myeloma
PHASE2This study will evaluate the efficacy and safety of LBH589B in adult patien...
Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma
PHASE2The purpose of this study was to evaluate the efficacy and safety of panobi...
Location
Novartis Investigative Site